Waddell & Reed Financial’s OptiNose OPTN Stock Holding History
Bought
Maintained
Sold
Other funds holding OPTN
FCMI
SW
RHJA
Waddell & Reed Financial's OPTN Position: Q2 2019 in Review
Waddell & Reed Financial sold out of OptiNose (OPTN) in Q2 2019, closing a stake of 73,761 shares — an estimated $11.4M sold.
Waddell & Reed Financial first reported a position in OPTN in Q4 2017 and held it in 6 quarters. The position peaked at $20.6M in Q2 2018. 73 funds tracked by Wall St. Rank hold OPTN as of Q2 2019.
- Waddell & Reed Financial reported no remaining OptiNose position as of Q2 2019 after selling out during the quarter.
- Waddell & Reed Financial sold 73,761 OptiNose shares in Q2 2019, an estimated $11.4M.
- Waddell & Reed Financial first reported a position in OptiNose in Q4 2017 and held it in 6 quarters.
- Waddell & Reed Financial's OptiNose position peaked at $20.6M in Q2 2018.
- 73 funds tracked by Wall St. Rank held OptiNose as of Q2 2019.
Based on Waddell & Reed Financial's 13F filing for Q2 2019, filed 14 Aug 2019.